|  Help  |  About  |  Contact Us

Publication : Loss of BPTF restores estrogen response and suppresses metastasis of mammary tumors.

First Author  Ciccone MF Year  2025
Journal  Nat Commun Volume  16
Issue  1 Pages  9168
PubMed ID  41093864 Mgi Jnum  J:373747
Mgi Id  MGI:8255945 Doi  10.1038/s41467-025-64255-8
Citation  Ciccone MF, et al. (2025) Loss of BPTF restores estrogen response and suppresses metastasis of mammary tumors. Nat Commun 16(1):9168
abstractText  Context-specific epigenetic dependencies, shaped by chromatin remodeling can create exploitable vulnerabilities for cancer therapies that are unique to tissue types and cellular identities. Here, we show that loss of BPTF (Bromodomain PHD Finger Transcription Factor), a core component of the NURF (Nucleosome Remodeling Factor) complex, results in the emergence of estrogen-responsive, tamoxifen-sensitive, Estrogen Receptor alpha (ERalpha) positive mammary tumors without altering cancer cell state and tumor pathology. Elevated ERalpha levels in BPTF(KO) mammary tumor cells are linked with decreased TGF-beta activity and limited metastatic spread of mammary tumor cells to the lungs. Loss of ERalpha is sufficient to restore TGF-beta activity and the metastatic potential in BPTF(KO) tumors. These findings highlight a mechanism through which BPTF regulates tumor development and progression in mammary epithelial cells, offering insights into the interplay between chromatin remodeling, estrogen signaling, and their resultant adjuvant therapeutic potential in breast cancer.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

10 Bio Entities

Trail: Publication

0 Expression